Dexerials Corporation (4980.T) Bundle
Curious whether Dexerials Corporation (4980.T) is a safe bet or a hidden gem? The company posted annual net sales of 110.39 billion yen for the fiscal year ending March 31, 2025 (a 4.94% rise year-over-year) yet shows a TTM revenue decline to 108.21 billion yen as of September 30, 2025, and a quarterly revenue dip of 3.52%; at the same time profitability shines with an operating profit margin of 35.65%, a net margin of 25.1%, EBITDA margin of 39.5% and EPS jumping to 162.0 yen (up 24.9%), while balance-sheet strength is evident in total assets of 158.78 billion yen, equity of 103.22 billion yen yielding an equity ratio around 65%, a conservative debt-to-equity of 0.22 and an Altman Z-Score of 6.08 - cash and equivalents sit at 22.38 billion yen with net cash of 3.12 billion yen and operating cash flow of 31.58 billion yen supporting free cash flow of 5.75 billion yen - valuation metrics show a P/E of 21.79, forward P/E of 18.76, market cap of 527.33 billion yen and a stock price of 3,117.00 yen (Dec 12, 2025), even as risks from potential FY2026 sales/profit declines, rising fixed costs for optical semiconductor investment, FX swings and product transitions could pressure near-term results; read on to unpack how these numbers, liquidity, leverage, valuation and strategic investments interplay for investors.
Dexerials Corporation (4980.T) - Revenue Analysis
Dexerials Corporation reported mixed topline signals across fiscal and trailing periods in 2025, with full-year fiscal growth offset by declines in more recent trailing and quarterly figures. Key figures highlight trajectory, operational efficiency and market valuation relative to sales.| Metric | Value | Change / Notes |
|---|---|---|
| Net sales (FY ended Mar 31, 2025) | 110.39 billion JPY | +4.94% YoY |
| TTM revenue (as of Sep 30, 2025) | 108.21 billion JPY | -6.10% YoY |
| Quarterly revenue (Q ended Sep 30, 2025) | (annualized components) - quarter down | -3.52% YoY for the quarter |
| Revenue per employee | ≈57.32 million JPY | Based on 1,888 employees |
| Price-to-Sales (P/S) | 4.77 | Market valuation relative to revenue |
- Fiscal year strength: FY Mar 31, 2025 net sales rose 4.94% to 110.39B JPY-evidence of annual demand recovery or one-off gains.
- Recent softness: TTM as of Sep 30, 2025 fell to 108.21B JPY (-6.10% YoY), indicating weaker revenue in the latest four quarters versus the prior year.
- Quarterly trend: The quarter ending Sep 30, 2025 recorded a 3.52% revenue decline YoY, showing near-term headwinds despite full-year growth.
- Operational efficiency: Revenue per employee ≈57.32M JPY, useful for benchmarking productivity and fixed-cost leverage against peers.
- Valuation lens: A P/S of 4.77 signals the market is valuing Dexerials at nearly 4.8x sales-investors should weigh growth prospects vs. this premium.
- Drivers to watch that could explain the mix of annual growth and recent declines:
- Product mix shifts or one-time contract/recognition timing boosting FY numbers.
- Demand softness or order timing pressure in the most recent quarter and trailing twelve months.
- Currency effects and pass-through pricing in global end markets.
Dexerials Corporation (4980.T) - Profitability Metrics
Dexerials Corporation (4980.T) delivered notably stronger profitability in the fiscal year ending March 31, 2025, driven by margin expansion, operating leverage and improved per‑share returns. Key headline figures show meaningful year‑over‑year improvements across operating profit, net income and EPS, reflecting effective pricing, cost control and higher operational efficiency.
- Operating profit margin: 35.65% (FY2025) vs. 29.36% (FY2024)
- Net profit margin: 25.1% (FY2025) vs. 22.5% (FY2024)
- EBITDA margin: 39.5% (FY2025)
- Gross profit margin: 55.37% (FY2025)
- Operating profit growth: +24.6% (FY2025 vs FY2024)
- Earnings per share (EPS): 162.0 yen (FY2025), +24.9% vs prior year
| Metric | FY2025 | FY2024 | YoY change |
|---|---|---|---|
| Operating profit margin | 35.65% | 29.36% | +6.29 pp |
| Net profit margin | 25.1% | 22.5% | +2.6 pp |
| EBITDA margin | 39.5% | - | - |
| Gross profit margin | 55.37% | - | - |
| Operating profit (growth) | +24.6% | - | +24.6% |
| EPS | 162.0 yen | 129.8 yen (implied) | +24.9% |
The margin profile suggests strong unit economics and robust cost management. Higher gross margin (55.37%) provides a wide buffer for SG&A and R&D while still delivering an elevated operating margin (35.65%). The EBITDA margin of 39.5% further indicates limited leakage between gross profit and core cash operating earnings.
- Primary drivers of improvement:
- Revenue mix shift toward higher‑margin products and services
- Operational efficiency gains and scale benefits
- Pricing actions and tighter variable cost control
- Investor implications:
- EPS growth of 24.9% supports valuation re‑rating potential if sustained
- High operating and EBITDA margins point to strong cash generation capability
For context on how these profitability improvements align with the company's strategic direction and longer‑term targets, see: Mission Statement, Vision, & Core Values (2026) of Dexerials Corporation.
Dexerials Corporation (4980.T) - Debt vs. Equity Structure
Dexerials Corporation (4980.T) presents a conservative capital structure characterized by a strong equity base and low leverage as of September 30, 2025. Key balance-sheet metrics underscore financial resilience and ample net asset backing for shareholders.- Total assets: 158.78 billion yen
- Total equity: 103.22 billion yen
- Equity ratio: ~65%
- Debt-to-equity ratio: 0.22
- Cash & cash equivalents: 22.38 billion yen
- Net cash position: 3.12 billion yen (decreased)
- Book value per share: 610.13 yen
- Altman Z-Score: 6.08 (low bankruptcy risk)
| Metric | Value |
|---|---|
| Total assets (Sept 30, 2025) | 158.78 billion yen |
| Total equity (Sept 30, 2025) | 103.22 billion yen |
| Equity ratio | ~65% |
| Debt-to-equity ratio | 0.22 |
| Cash & cash equivalents | 22.38 billion yen |
| Net cash position | 3.12 billion yen |
| Book value per share | 610.13 yen |
| Altman Z-Score | 6.08 |
Dexerials Corporation (4980.T) - Liquidity and Solvency
Dexerials Corporation demonstrates solid short-term liquidity and reliable cash-generation capacity through FY ending March 31, 2025 and interim figures to September 30, 2025. Key metrics point to a comfortable buffer against short-term obligations and the capacity to fund operations and investments from internally generated cash.
- Current ratio: 2.5 - current assets cover current liabilities by 2.5x, indicating good short-term financial health.
- Quick ratio: 1.8 - excluding inventory, Dexerials maintains strong immediate liquidity.
- Operating cash flow (FY ending Mar 31, 2025): ¥31.58 billion - robust cash generation from operations.
- Free cash flow (FY ending Mar 31, 2025): ¥5.75 billion - positive cash after capital expenditures.
- Cash and cash equivalents (as of Sep 30, 2025): ¥22.38 billion - a solid liquidity buffer on the balance sheet.
- Operating cash flow to net income ratio: 1.46 - cash generation exceeds reported net income, signaling earnings quality.
| Metric | Value | Period / Date |
|---|---|---|
| Current ratio | 2.5 | Most recent reporting |
| Quick ratio | 1.8 | Most recent reporting |
| Operating cash flow | ¥31.58 billion | FY ended Mar 31, 2025 |
| Free cash flow | ¥5.75 billion | FY ended Mar 31, 2025 |
| Cash & cash equivalents | ¥22.38 billion | As of Sep 30, 2025 |
| OCF to Net Income Ratio | 1.46 | FY ended Mar 31, 2025 |
These figures, combined with ongoing operational cash generation, provide Dexerials with flexibility for working capital management, reinvestment, and the ability to withstand short-term liquidity stress. For further context on corporate direction and allocation priorities, see Mission Statement, Vision, & Core Values (2026) of Dexerials Corporation.
Dexerials Corporation (4980.T) - Valuation Analysis
Dexerials Corporation (4980.T) on December 12, 2025 presented a valuation profile consistent with a company priced for moderate growth and steady shareholder returns. Key market metrics point to an investor view that anticipates earnings expansion while maintaining disciplined cash returns.- Trailing P/E: 21.79 - indicates the market is paying roughly 22 times last 12 months' earnings, a moderate premium versus defensive or cyclical peers.
- Forward P/E: 18.76 - implies expected earnings growth or margin improvement, lowering the multiple investors are willing to pay on forecasted earnings.
- Dividend yield: 1.86% with an annual cash dividend of ¥58.00 per share - provides income, albeit modest relative to high-yield sectors.
- Payout ratio: 40.54% - demonstrates a balanced return-of-capital policy, retaining ~59.5% of earnings for reinvestment or cushioning.
- Market capitalization: ¥527.33 billion - places the company in the mid-cap range on the Tokyo exchange as of the cited date.
- Share price: ¥3,117.00 (up 2.70% on the day) - reflects market sentiment and intraday momentum as of December 12, 2025.
| Metric | Value | Interpretation |
|---|---|---|
| Price-to-Earnings (TTM) | 21.79 | Moderate valuation; suggests market confidence in historical profitability |
| Forward P/E | 18.76 | Market expects earnings to rise or margin recovery |
| Dividend (Annual) | ¥58.00 | Annual cash return per share |
| Dividend Yield | 1.86% | Conservative income component for investors |
| Payout Ratio | 40.54% | Balanced distribution vs. reinvestment |
| Market Capitalization | ¥527.33 billion | Mid-cap scale on 4980.T |
| Share Price (12-Dec-2025) | ¥3,117.00 | +2.70% vs previous close |
- Relative attractiveness: P/E of 21.79 vs forward P/E 18.76 signals expected earnings acceleration - the gap (~3.03 points) quantifies market-implied growth expectations.
- Income vs growth mix: 1.86% yield and 40.54% payout ratio point to a hybrid profile - some cash return without overly constraining reinvestment.
- Market cap and liquidity: ¥527.33 billion supports institutional coverage while keeping exposure to medium-cap volatility.
- Price movement: the +2.70% intraday change to ¥3,117 may reflect news flow, earnings revisions, or broader market rotation; investors should watch forward guidance and analyst revisions that underpin the forward P/E.
Dexerials Corporation (4980.T) - Risk Factors
Dexerials Corporation (4980.T) faces multiple interrelated risks that may materially affect near‑term financial performance, capital allocation and shareholder returns. The items below synthesize the principal vulnerabilities investors should monitor, with quantification where relevant.- Decline in net sales and profits for FY ending March 31, 2026
| Scenario | Net Sales Change (FY2026 vs FY2025) | Operating Profit Change | Notes |
|---|---|---|---|
| Base | -5% | -8% | Moderate market softening |
| Downside | -12% | -20% | Sharp demand drop for display components |
| Severe | -20% | -35% | Combination of lost ARF volumes and phosphor film exit |
- Increased fixed costs from growth investments, especially optical semiconductors
| Item | FY2024 Actual (JPY bn) | FY2025 Budget/Plan (JPY bn) |
|---|---|---|
| CapEx (total) | ~8.5 | ~18.0 |
| R&D spend | ~6.0 | ~7.5 |
| Incremental fixed (annualized) | - | ~3.0-5.0 |
- Currency exchange rate fluctuations
| FX Move | Estimated Annual Impact on Operating Profit (JPY bn) |
|---|---|
| ¥1 appreciation vs USD | -0.6 |
| ¥1 depreciation vs USD | +0.6 |
- End of phosphor films and reduced ARF deliveries
| Product | Recent Annual Revenue Contribution (est., JPY bn) | Risk |
|---|---|---|
| Phosphor films | ~4.0 | Revenue falls to near‑zero upon exit |
| ARF (reduced delivery) | ~6.0 | Partial replacement required via new products |
- Market competition
| Segment | Competitive Pressure | Implication |
|---|---|---|
| Adhesives & films | High (commodity migration) | Margin compression |
| Optical semiconductors | Medium-High (capex race) | Need for scale and IP to win contracts |
- Macro and demand sensitivity for electronic components
- Liquidity & leverage metrics: rising capex increases free‑cash‑flow strain - monitor net debt to EBITDA trajectory.
- Product concentration: displacement of phosphor/ARF must be offset by scaled adoption of new optical products.
- Execution risk: timeline to reach utilization rates required to absorb incremental fixed costs.
Dexerials Corporation (4980.T) - Growth Opportunities
Dexerials Corporation (4980.T) is pivoting toward higher-value-added products and markets - notably optical semiconductors and advanced electronic materials - to lift margins and diversify revenue. The company's strategic focus combines product mix shift, R&D intensity, selective capital allocation, and partnerships to capture expanding end-market demand.- High-value product focus: accelerating development and commercialization of optical semiconductor components, precision adhesives, and advanced bonding films aimed at automotive, industrial, and consumer optics.
- R&D-led innovation: maintaining elevated R&D investment to shorten time-to-market for next-generation optical modules and surface-treatment chemistries (company statements indicate R&D is a key budget priority).
- Market expansion: targeting growing optical-sensing applications (automotive LiDAR, AR/VR optics, industrial imaging) to broaden addressable markets beyond legacy connector and tape businesses.
- Capital allocation balance: pursuing a mix of share buybacks and reinvestment - management has signalled continued buybacks while reserving funds for strategic capex and product development.
- Partnerships and collaborations: engaging OEMs, device makers and research institutes to co-develop optical subassemblies and accelerate qualification cycles for high-reliability markets.
- Application diversification: exploring new end-markets (medical optics, semiconductor lithography support materials, automative ADAS sensors) to reduce cyclicality and concentration risk.
| Area | Target / Focus | Indicative Metrics / Notes |
|---|---|---|
| Optical semiconductors | Scale production, expand product lineup | Addressable market expected to grow rapidly; company prioritizing module qualification and yield improvements |
| R&D | New materials, optical modules | Ongoing investments to accelerate commercialization; emphasis on applied R&D and pilot lines |
| Capital allocation | Share buybacks + capex balance | Management targets shareholder returns while preserving investment capacity for growth initiatives |
| Market expansion | Automotive, AR/VR, medical | Diversification to reduce dependence on legacy segments and capture higher-margin applications |
| Partnerships | OEMs, research labs | Co-development to shorten qualification cycles and secure early design wins |
- Near-term growth levers: ramp of optical-semiconductor product shipments, improved ASPs from higher-value mix, and expanded sales into automotive and industrial channels.
- Operational actions: scale pilot production, improve yields, localize supply for priority customers, and strengthen IP around optical-material formulations.
- Financial considerations: effective growth execution will require sustained R&D and selective capex; management's stated buyback plans suggest a desire to keep ROE attractive while funding expansion.

Dexerials Corporation (4980.T) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.